Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Actos (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 12
» View herald-mail.com items only
    May 12, 2013 |Story| Herald Mail

  1. Shop around for deals on prescription drugs

    If your insurance has ever stopped covering a prescription drug or you don’t have coverage at all, you know how quickly costs can mount. Americans spent, on average, $758 out of pocket for medication in 2012, according to a recent Consumer Reports...

    Tags: CVS Corp., Statins (drugs), Prices, Plavix (drug), Diabetes

    2. Apr 15, 2013 |Story| WSBT-TV

  2. CONSUMER REPORTS: Big name drug savings

    If you take Lipitor, Actos, or Lexapro, new generics of these and other big-name drugs could be a real money saver.
    If you take Lipitor, Actos, or Lexapro, new generics of these and other big-name drugs could be a real money saver. But are you saving as much as you should? Consumer Reports has discovered just because you're buying a generic drug doesn't mean you're...

    Tags: CVS Corp., Statins (drugs), Plavix (drug), Diabetes, Consumers

    3. Mar 25, 2013 |Story| Los Angeles Times

  3. Girardi | Keese

    Given its deep bench of skilled trial attorneys—who include partner Amy Fisch Solomon —Girardi | Keese has pioneered litigation in the personal injury field, achieving more than $10 billion for its injured clients. “Amy is truly one of...

    Tags: Laws, Lawyers, Crime, Law and Justice, Trials, Vioxx (drug)

    4. Aug 1, 2012 |Story| Chicago Tribune

  4. What drugs are going generic this year and next

    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic Pharmaceutical Association.
    Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...

    Tags: Behavioral Conditions, COPD, Osteoporosis, Diabetes, Allergies

    5. Mar 26, 2012 |Story| Los Angeles Times

  5. Robinson Calcagnie Robinson Shapiro Davis, Inc.

    From defective cars to dangerous drugs to hazardous roadways, the firm has represented thousands of clients in individual suits, class actions and mass torts over the past four decades.
    From defective cars to dangerous drugs to hazardous roadways, the firm has represented thousands of clients in individual suits, class actions and mass torts over the past four decades. Robinson Calcagnie Robinson Shapiro Davis, Inc. specializes in...

    Tags: Air and Space Accidents, Commuting, Cancer, Manufacturing and Engineering, Labor Legislation

    6. Nov 30, 2011 |Story| Los Angeles Times
  6. |Story
    7. Feb 7, 2011 |Story| Reuters
  7. |Story

    Tags: IMS Health Incorporated, GlaxoSmithKline PLC, Crime, Law and Justice, Trials, Diabetes

    8. Oct 26, 2009 |Story| Los Angeles Times

  8. Patients kick the insulin habit through diet, exercise

    By harnessing the power of lifestyle, the following people are managing their Type 2 diabetes without insulin, and in some cases without any medication at all. Some made the commitment when they were first diagnosed, but others reversed a condition that had been spiraling downward for years. Here's how they did it:
    By harnessing the power of lifestyle, the following people are managing their Type 2 diabetes without insulin, and in some cases without any medication at all. Some made the commitment when they were first diagnosed, but others reversed a condition that...

    Tags: Weight Loss, Diabetes, Social Issues, Cancer, Drugs and Medicines

    9. Dec 4, 2009 | Los Angeles Times

  9. Sulfonylureas for diabetes increase risk of heart disease and death, study finds

    Booster Shots
    Sulfonylureas, the first family of oral drugs used for treating type 2 diabetes, increase the risk of death from all causes by as much as 61% compared with the newer drug metformin, British researchers have found. Some researchers have suspected......
    10. Jun 29, 2010 |Story| Los Angeles Times

  10. For Diabetes Drug Avandia, Bad News Continues

    The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke. The research comes only weeks before an upcoming federal hearing to reconsider its fate.
    Los Angeles Times
    The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke....

    Tags: Heart and Circulatory System, GlaxoSmithKline PLC, Los Angeles Times, Crime, Law and Justice, Trials

    11. Jun 30, 2010 |Story| Health Portal

  11. The Avandia Dilemma

    The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on.
    Staff Writer
    The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to stay on the market? Drug safety...

    Tags: GlaxoSmithKline PLC, Science and Technology, Plastic Surgeons, Diabetes, Health Organizations

    12. Jul 15, 2010 |Story| Los Angeles Times

  12. FDA: Avandia Should Stay With Restrictions

    Los Angeles Times
    Faced with conflicting and less-than-conclusive scientific evidence, a Food and Drug Administration advisory panel recommended Wednesday that the controversial diabetes drug Avandia remain on the market — but with tighter supervision and increased...

    Tags: Heart and Circulatory System, IMS Health Incorporated, GlaxoSmithKline PLC, Los Angeles Times, Science and Technology

Original site for Actos (drug) topic gallery.